Search / Trial NCT06227793

Pragmatic Clinical Trial to Assess the Effectiveness of Pharmaceutical Intervention in Patients With Uncontrolled Asthma

Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Jan 18, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

Asthma is a heterogeneous disease, typically characterized by chronic inflammation of the airways. Uncontrolled asthma is a condition that can directly impact patients' quality of life and be associated with non-adherence to treatment and errors in inhalation technique. It is known that pharmaceutical monitoring contributes positively to asthma control. Thus, the aim of this study is to evaluate the effectiveness of pharmaceutical intervention in controlling asthma in patients diagnosed with uncontrolled asthma. This is a pragmatic clinical trial composed of two groups - intervention (pharm...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Age from 18 to 70 years.
  • * Previous diagnosis of asthma according to clinical and pulmonary functional criteria, established in national and international guidelines.
  • * Present uncontrolled asthma as assessed by the ACT (score below 20 points) (32).
  • * Be undergoing outpatient treatment at the Pulmonology Service of HCPA for at least 6 months and have had at least 2 prior consultations.
  • * Reside in Porto Alegre or in the metropolitan region of Porto Alegre.
  • * Smoking index less than 10 pack-years (number of cigarettes smoked per day / 20 cigarettes x number of years of smoking).
  • Exclusion Criteria:
  • * Pregnant patients
  • * Chronic neurological or psychiatric diseases that prevent the execution of study procedures
  • * Pulmonary comorbidities such as chronic obstructive pulmonary disease, diffuse bronchiectasis, extensive sequelae of tuberculosis, diffuse pulmonary fibrosis.
  • * Lung neoplasms or from other sites.
  • * Incapacitating cardiovascular diseases
  • * Patients without access to WhatsApp.

About Hospital De Clinicas De Porto Alegre

Hospital de Clínicas de Porto Alegre (HCPA) is a leading academic medical center in Brazil, renowned for its commitment to advancing healthcare through innovative clinical research. As a sponsor of clinical trials, HCPA leverages its extensive expertise in various medical disciplines to conduct rigorous studies aimed at improving patient outcomes and contributing to the global medical community. With a multidisciplinary team of skilled professionals and state-of-the-art facilities, HCPA fosters a collaborative environment that prioritizes ethical standards, patient safety, and scientific integrity in all its research endeavors.

Locations

Porto Alegre, Rio Grande Do Sul, Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0